Listing Date Delayed for Capital Increase
한국유니온제약
080720
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2604
Risk-adjusted indicator based on 2604 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • New Listing Date: August 5, 2026
- • Original Listing Date: July 29, 2026
- • Court Approval Date for Rehabilitation Plan: May 12, 2026
- • Debt-to-Equity Conversion Effective Date: May 19, 2026
- • Capital Reduction (Share Consolidation) Effective Date: May 27, 2026
- • Third-Party Allotment Capital Increase Effective Date: May 28, 2026
AI Analysis Summary
UNION KOREA PHARM CO.,Ltd announced an amendment to its Material Fact Report regarding a paid-in capital increase. The new listing date for the new shares has been delayed from July 29, 2026, to August 5, 2026, due to administrative procedures with the Korea Securities Depository. The company received court approval for its rehabilitation plan on May 12, 2026, and is proceeding with a debt-to-equity conversion (May 19, 2026), capital reduction (May 27, 2026), and a third-party allotment capital increase (May 28, 2026). The capital increase is part of the rehabilitation plan, and the maximum shareholder dilution rate cannot be determined from the provided text as the number of shares and issuance price are not disclosed. The company's largest shareholder is expected to change following this third-party allotment. The delay in listing is a minor procedural change.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.